GF Fund Management
UTHR icon

GF Fund Management’s United Therapeutics UTHR Stock Holding History

GF Fund Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$617K Buy
1,139
+299
+36% +$155K 0.01% 205
2026
Q2 		$455K Sell
840
-127
-13% -$71.5K 0.01% 221
2026
Q1 		$573K Buy
967
+122
+14% +$60.8K 0.01% 213
2025
Q4 		$412K Sell
845
-128
-13% -$59.6K 0.01% 236
2025
Q3 		$408K Sell
973
-170
-15% -$57.2K 0.01% 235
2025
Q2 		$328K Hold
1,143
– – 0.01% 281
2025
Q1 		$352K Buy
1,143
+206
+22% +$70.6K 0.01% 283
2024
Q4 		$331K Buy
+937
New +$344K 0.01% 253

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

GF Fund Management's UTHR Position: Q3 2026 in Review

GF Fund Management increased its United Therapeutics (UTHR) stake by 36% in Q3 2026, buying an estimated $155K and bringing the position to 1,139 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #205.

GF Fund Management first reported a position in UTHR in Q4 2024 and has held it in 8 quarters since. 202 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • GF Fund Management held 1,139 shares of United Therapeutics worth $617K as of Q3 2026.
  • GF Fund Management bought 299 United Therapeutics shares in Q3 2026, an estimated $155K.
  • United Therapeutics made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #205 holding.
  • GF Fund Management first reported a position in United Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 202 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.